Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
about
Neurohormonal profile of patients with heart failure and diabetesRecent advances in natriuretic peptide researchSimultaneous predictive value of NT-proBNP and CA-125 in patients newly diagnosed with advanced heart failure: preliminary resultsN-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohortReview Of Obesity And Atrial Fibrillation: Exploring The Paradox.In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio.CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial.Comparative accuracy of NT-proBNP and MR-proANP for the diagnosis of acute heart failure in dyspnoeic patientsCardiac gene expression profiling - the quest for an atrium-specific biomarker.Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.Atrial fibrillation down-regulates renal neutral endopeptidase expression and induces profibrotic pathways in the kidney.Natriuretic Peptides as Cardiovascular Safety Biomarkers in Rats: Comparison With Blood Pressure, Heart Rate, and Heart Weight.Biomarkers in Persistent AF and Heart Failure: Impact of Catheter Ablation Compared with Rate Control.
P2860
Q33799053-5C3874F8-0631-4B51-84E6-78A7AD87162AQ35459776-E37FBC40-8AF2-40EF-B95E-A2B9A91B3135Q36286287-F7E45AA9-D6A4-46B1-8B25-9ADCBC25101EQ36494211-E59FA3F6-A5AC-4A61-AC60-F3206A884855Q37468906-74953CBC-BFA7-48B2-89AB-FB0693472930Q38623581-E3618FCF-A20F-475A-BB24-4BB97743BCB8Q38826501-10F8DD58-B57B-4187-83C9-5A483B18703BQ39055218-53F06E0B-B428-48ED-9F3E-883EAAB0A332Q41239151-186EE4F4-BB5D-4877-BF0F-935694DBBEF7Q41875691-E6134499-A927-41B4-AA54-7AE029A519F3Q44273778-571EC1D7-9A89-4D39-A406-76C3CDDD7967Q45206840-33F753FB-1CF0-4603-A575-75AAB967FDDCQ46438817-FF1C8B95-DD33-42BA-B52D-97F0A860EA57Q47344464-3B80AC5D-C3E9-48AA-923B-767E78E9A463Q48614840-B6AAA397-DBFF-45AC-AFB5-8D5B1A188129
P2860
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Natriuretic peptides in patien ...... e of (NT-)ANP and (NT-pro)BNP.
@en
Natriuretic peptides in patien ...... inants and prognostic value of
@nl
type
label
Natriuretic peptides in patien ...... e of (NT-)ANP and (NT-pro)BNP.
@en
Natriuretic peptides in patien ...... inants and prognostic value of
@nl
prefLabel
Natriuretic peptides in patien ...... e of (NT-)ANP and (NT-pro)BNP.
@en
Natriuretic peptides in patien ...... inants and prognostic value of
@nl
P2093
P2860
P356
P1433
P1476
Natriuretic peptides in patien ...... e of (NT-)ANP and (NT-pro)BNP.
@en
P2093
Dirk J Van Veldhuisen
Frans Boomsma
Maarten P Van den Berg
P2860
P304
P356
10.1093/EUROPACE/EUL060
P577
2006-07-01T00:00:00Z